Deutsche Bank’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Deutsche Bank's AQST Position: Q3 2026 in Review
Deutsche Bank reduced its Aquestive Therapeutics (AQST) stake by 13% in Q3 2026, selling an estimated $59.2K and leaving 92,706 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #2708.
Deutsche Bank first reported a position in AQST in Q3 2018 and has held it in 19 quarters since. The position peaked at $539K in Q4 2025. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Deutsche Bank held 92,706 shares of Aquestive Therapeutics worth $429K as of Q3 2026.
- Deutsche Bank sold 13,322 Aquestive Therapeutics shares in Q3 2026, an estimated $59.2K.
- Aquestive Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2708 holding.
- Deutsche Bank first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 19 quarters since.
- Deutsche Bank's Aquestive Therapeutics position peaked at $539K in Q4 2025.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.